VYGR NASDAQ
Voyager Therapeutics, Inc.
1W: -8.6%
1M: -30.8%
3M: -32.3%
YTD: -39.2%
1Y: -47.6%
3Y: -68.3%
5Y: -16.7%
$2.45
-0.23 (-8.41%)
Weekly Expected Move ±7.2%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$34M
Revenue
-19.1% YoY
$-108M
Net Income
+0.2% YoY
$-121M
Free Cash Flow
-4.8% YoY
100.0%
Gross Margin
-833.9%
Op. Margin
-773.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-54.1%
ROA-41.4%
ROIC-131.1%
Valuation
P/E-1.4
P/B1.0
EV/EBITDA-1.2
Leverage
Debt/Equity0.21
Current Ratio7.51
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-1.56
Beneish M-1.72